Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial
Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page
- Check6 days agoChange DetectedA new revision label v3.5.4 was added, replacing the previous v3.5.3 to denote a minor build/version update for the page. This reflects maintenance or a status update rather than changes to study information or outcomes.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, signaling an updated version of the page documentation. Aside from this metadata update, the page content and structure appear unchanged.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedFooter shows site revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedAdministrative revision update: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no study data or page content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.